- Home
- HUM vs CBOE Comparison
HUM vs CBOE Comparison
Compare HUM & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUM | CBOE |
|---|---|---|
| Founded | 1961 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3B | 26.8B |
| IPO Year | 1993 | 2010 |
Fundamental Metrics
Financial Performance| Metric | HUM | CBOE |
|---|---|---|
| Price | $184.77 | $284.05 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 20 | 9 |
| Target Price | $258.40 | ★ $271.00 |
| AVG Volume (30 Days) | ★ 3.1M | 488.3K |
| Earning Date | 02-11-2026 | 02-06-2026 |
| Dividend Yield | ★ 1.92% | 1.05% |
| EPS Growth | N/A | ★ 44.52 |
| EPS | 9.84 | ★ 10.42 |
| Revenue | ★ $129,664,000,000.00 | $4,714,200,000.00 |
| Revenue This Year | $13.19 | N/A |
| Revenue Next Year | $7.87 | $3.69 |
| P/E Ratio | ★ $18.71 | $26.40 |
| Revenue Growth | 10.11 | ★ 15.13 |
| 52 Week Low | $169.61 | $200.88 |
| 52 Week High | $315.35 | $283.05 |
Technical Indicators
Market Signals| Indicator | HUM | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 30.43 | 64.49 |
| Support Level | $169.61 | $267.50 |
| Resistance Level | $196.75 | $283.13 |
| Average True Range (ATR) | 7.99 | 7.73 |
| MACD | -0.86 | 0.35 |
| Stochastic Oscillator | 42.34 | 92.64 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.